Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes

Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes

HER2+ breast cancer (BC) is an aggressive subtype representing a genetically and biologically heterogeneous group of tumors resulting in variable prognosis and treatment response to HER2-targeted therapies according to estrogen (ER) and progesterone receptor (PR) expression. The relationship with an...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Sandra Orrù, Emanuele Pascariello, Giovanni Sotgiu, Daniela Piras, Laura Saderi, Maria Rosaria Muroni, Ciriaco Carru, Caterina Arru, Cristina Mocci, Giampietro Pinna, Raffaele Barbara, Paolo Cossu-Rocca, Maria Rosaria De Miglio
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: MDPI AG 2022-01-01
Sarja:Biomedicines
Aiheet:
HER2 expression
AR expression
breast cancer
prognosis
immunohistochemistry
Linkit:https://www.mdpi.com/2227-9059/10/1/164

Internet

https://www.mdpi.com/2227-9059/10/1/164

Samankaltaisia teoksia